Literature DB >> 10928366

B cells are the principal circulating mononuclear cells infected by dengue virus.

A D King1, A Nisalak, S Kalayanrooj, K S Myint, K Pattanapanyasat, S Nimmannitya, B L Innis.   

Abstract

Although dengue virus infects a variety of cells in vitro, little is known about cell types infected in vivo. Since blood is a readily accessible tissue, we chose to determine which circulating blood cells are infected by dengue viruses. We collected blood mononuclear cells from acutely ill dengue patients and separated the cells by flow cytometry into subsets for virus isolation. Cells were sorted into groups corresponding to the cluster designations CD3, CD14, CD16 and CD20. Virus was isolated from sorted groups by inoculation into Toxorhynchites splendens mosquitos. The majority of the virus was recovered from the CD20 or B cell positive subset. Little virus was isolated from monocytes, NK cells or T cells. Virus was isolated from B cells regardless of the age or sex of the patient, virus serotype isolated, or the patient's history of dengue virus infection. The location of cell associated virus was determined by proteolytic digestion of surface virus. There was an equal distribution of virus between the intracellular compartment and the surface of B cells. The intracellular localization of virus was confirmed by immunocytochemistry. Since this study focused on circulating cells, no inferences were made regarding infection of cells in solid tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10928366

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  31 in total

Review 1.  Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis.

Authors:  Karen Clyde; Jennifer L Kyle; Eva Harris
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

Review 2.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

3.  Virus replication and cytokine production in dengue virus-infected human B lymphocytes.

Authors:  Yu-Wen Lin; Kuan-Ju Wang; Huan-Yao Lei; Yee-Shin Lin; Trai-Ming Yeh; Hsiao-Sheng Liu; Ching-Chuan Liu; Shun-Hua Chen
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Human T Lymphocytes Are Permissive for Dengue Virus Replication.

Authors:  Guilherme F Silveira; Pryscilla F Wowk; Allan H D Cataneo; Paula F Dos Santos; Murilo Delgobo; Marco A Stimamiglio; Maria Lo Sarzi; Ana Paula F S Thomazelli; Ivete Conchon-Costa; Wander R Pavanelli; Lis R V Antonelli; André Báfica; Daniel S Mansur; Claudia N Duarte Dos Santos; Juliano Bordignon
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

5.  Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing.

Authors:  Natalia Frias-Staheli; Marcus Dorner; Svetlana Marukian; Eva Billerbeck; Rachael N Labitt; Charles M Rice; Alexander Ploss
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

Review 6.  Molecular mechanisms involved in the early steps of flavivirus cell entry.

Authors:  Bärbel Kaufmann; Michael G Rossmann
Journal:  Microbes Infect       Date:  2010-12-10       Impact factor: 2.700

7.  Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever.

Authors:  Anna P Durbin; Maria José Vargas; Kimberli Wanionek; Samantha N Hammond; Aubree Gordon; Crisanta Rocha; Angel Balmaseda; Eva Harris
Journal:  Virology       Date:  2008-05-02       Impact factor: 3.616

8.  Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro.

Authors:  Shanley Blackley; Zhihua Kou; Huiyuan Chen; Matthew Quinn; Robert C Rose; Jacob J Schlesinger; Myra Coppage; Xia Jin
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

9.  TRAIL is a novel antiviral protein against dengue virus.

Authors:  Rajas V Warke; Katherine J Martin; Kris Giaya; Sunil K Shaw; Alan L Rothman; Irene Bosch
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

Review 10.  Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.

Authors:  Carlo Amorin Daep; Jorge L Muñoz-Jordán; Eliseo Alberto Eugenin
Journal:  J Neurovirol       Date:  2014-10-07       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.